CLINICAL REPORT
Evaluation for Bleeding Disorders in Suspected ChildAbuse
abstractBruising or bleeding in a child can raise the concern for child abuse.Assessing whether the findings are the result of trauma and/orwhether the child has a bleeding disorder is critical. Many bleedingdisorders are rare, and not every child with bruising/bleeding concern-ing for abuse requires an evaluation for bleeding disorders. In someinstances, however, bleeding disorders can present in a manner sim-ilar to child abuse. The history and clinical evaluation can be used todetermine the necessity of an evaluation for a possible bleeding dis-order, and prevalence and known clinical presentations of individualbleeding disorders can be used to guide the extent of the laboratorytesting. This clinical report provides guidance to pediatricians andother clinicians regarding the evaluation for bleeding disorders whenchild abuse is suspected. Pediatrics 2013;131:e1314–e1322
INTRODUCTION
Children often present for medical care with bleeding or bruising thatcan raise a concern for child abuse. Most commonly, this occurs withcutaneous bruises and intracranial hemorrhage (ICH), but otherpresentations, such as hematemesis,1 hematochezia,2 and oronasalbleeding can be caused by child abuse and/or bleeding disorders.3–7
When bleeding or bruising is suspicious for child abuse, carefulconsideration of medical and other causes is warranted. The in-appropriate diagnosis of child abuse could occur,8–10 potentiallyresulting in the removal of a child from a home and/or the potentialprosecution of an innocent person. Conversely, attributing an abusiveinjury to medical causes or accidental injury puts a child at risk forfuture abuse and possible death.11 Laboratory evaluations should beconducted with the understanding that the presence of a bleedingdisorder does not rule out abuse as the etiology for bruising orbleeding.9 Similarly, the presence of a history of trauma (accidental ornonaccidental) does not exclude the presence of a bleeding disorderor other medical condition. This clinical report provides guidance topediatricians and other clinicians regarding the evaluation forbleeding disorders when child abuse is suspected (Fig 1).
James D. Anderst, MD, MS, Shannon L. Carpenter, MD, MS,Thomas C. Abshire, MD and the SECTION ON HEMATOLOGY/ONCOLOGY and COMMITTEE ON CHILD ABUSE AND NEGLECT
KEY WORDSintracranial hemorrhage, inherited coagulation disorders,bruising, nonaccidental trauma
ABBREVIATIONSaPTT—activated partial thromboplastin timeDIC—disseminated intravascular coagulationICH—intracranial hemorrhageITP—immune thrombocytopeniaPFA-100—platelet function analyzerPT—prothrombin timeVKDB—vitamin K deficiency bleedingVWD—von Willebrand disease
This document is copyrighted and is property of the AmericanAcademy of Pediatrics and its Board of Directors. All authorshave filed conflict of interest statements with the AmericanAcademy of Pediatrics. Any conflicts have been resolved througha process approved by the Board of Directors. The AmericanAcademy of Pediatrics has neither solicited nor accepted anycommercial involvement in the development of the content ofthis publication.
The guidance in this report does not indicate an exclusivecourse of treatment or serve as a standard of medical care.Variations, taking into account individual circumstances, may beappropriate.
Accepted for publication Jan 23, 2013
www.pediatrics.org/cgi/doi/10.1542/peds.2013-0195
doi:10.1542/peds.2013-0195
All clinical reports from the American Academy of Pediatricsautomatically expire 5 years after publication unless reaffirmed,revised, or retired at or before that time.
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
Copyright © 2013 by the American Academy of Pediatrics
e1314 FROM THE AMERICAN ACADEMY OF PEDIATRICS
Guidance for the Clinician inRendering Pediatric Care
by guest on July 7, 2016Downloaded from
ASSESSING THE NEED FORA LABORATORY EVALUATION FORBLEEDING DISORDERS
The age and developmental capa-bilities of the child, history of trauma,the location and pattern of bruising,and, in the case of ICH, findings onneuroimaging should be consideredwhen assessing children with bruising/bleeding for possible abuse.12–18 Addi-tionally, a medical history of symptomssuggestive of a bleeding disorder, suchas significant bleeding after a circum-cision or other surgery, epistaxis,bleeding from the umbilical stump, or
excessive bleeding after dental proce-dures, increases the possibility ofa bleeding disorder. Family history ofa specific bleeding disorder or ethnic-ity of a population with higher ratesof a certain bleeding disorder (eg,Amish) might necessitate testing forthat condition. The child’s medicationsshould be documented, because cer-tain drugs can affect the results ofsome tests that might be used todetect bleeding disorders, such asthe platelet function analyzer (PFA-100; Siemens Healthcare Diagnostics,Tarrytown, NY) and platelet aggrega-tion testing. Caregivers might state
that their child “bruises easily.” Thesestatements are difficult to assess dur-ing an evaluation for possible abuse,as they can be a sign of a bleedingdisorder, a reflection of the child’s(fair) skin tone, or a fabrication tomask abuse. Children who are verbaland capable of providing a historyshould be interviewed away from po-tential offending caregivers, if possible.A thorough physical examinationshould include an evaluation of areasof bruising that have higher specificityfor abuse,14 such as the buttocks, ears,and genitals.
Any bleeding disorder can cause cu-taneous bruising, and sometimes thisbruising can be mild, can appear inlocations that are considered suspi-cious for abuse,19 and can appear atany age. Given the extreme rarity ofsome bleeding disorders, it is notreasonable to perform extensive lab-oratory testing for bleeding disordersin every child. In some cases, theconstellation of findings, taken inconjunction with the clinical historyand physical examination, can be sostrongly consistent with an abusiveinjury that further laboratory in-vestigation for medical conditions isnot warranted. For instance, a childwith a patterned slap mark whodescribes being hit with an open handdoes not require a laboratory evalua-tion for a bleeding disorder.
In addition to bleeding disorders, thepossibility of other medical causes ofeasy bruising or bleeding, such asEhlers-Danlos syndrome, scurvy, can-cer and other infiltrative disorders,glutaric aciduria, and arteriovenousmalformations, should be assessed,as should a history of use of anymedications or alternative therapiesthat may increase bleeding/bruising.Comprehensive descriptions of medi-cal conditions that could be confusedwith child abuse and alternativetherapies that may predispose to
FIGURE 1Recommended pathway for evaluation of possible bleeding disorders when child abuse is suspected.VWF, von Willebrand factor.
PEDIATRICS Volume 131, Number 4, April 2013 e1315
FROM THE AMERICAN ACADEMY OF PEDIATRICS
by guest on July 7, 2016Downloaded from
bleeding/bruising are beyond the scopeof this report and can be found else-where.20,21 Results of the history, re-view of systems, physical examination,and, in the case of ICH, neuroimagingare generally adequate to excludethese conditions. When there are con-cerns that a medical condition mightbe the cause of bruising or bleeding,the evaluation for the conditions inquestion should occur simultaneouslywith the evaluation for abuse.
Bruising
In the absence of independently wit-nessed accidental trauma or a knownmedical cause, any bruising in a non-mobile child is highly concerning forabuse and necessitates an evalua-tion for child abuse.12–15 Additionally,bruising in a young infant could alsobe the first presentation of a bleedingdisorder.19 As such, a simultaneousevaluation for bleeding disorders isrecommended in these cases. In mo-bile children, the locations and pat-terns of the bruising can be used toassess for the possibility of abuse(Table 1).
In cases of bruising, the assessment ofthe need for an evaluation for bleedingdisorders should focus on the following:
� the specific history offered to ex-plain the bruising;
� the nature and location of bruis-ing; and
� mobility and developmental statusof the child.
The following factors generally excludethe need for an evaluation fora bleeding disorder:
� the caregivers’ description oftrauma sufficiently explains thebruising;
� the child or an independent wit-ness is able to provide a historyof abuse or nonabusive traumathat explains the bruising; or
� abusive object or hand-patternedbruising is present.
The injury history offered by care-givers might be purposefully mis-leading if the caregivers have causedthe bruising by abusive means.
In nonmobile infants, bleeding dis-orders can present with bruising orpetechiae in sites of normal handlingor pressure. Examples of this includethe following:
� petechiae at clothing line pressuresites;
� bruising at sites of object pres-sure, such as in the pattern andlocation of infant seat fasteners;and
� excessive diffuse bleeding if thechild has a severe bleeding disor-der.
Absence of these examples does notrule out a bleeding disorder; however,their presence might increase theprobability of a bleeding disorder.
ICH
Excepting obvious known trauma, ICHin a nonmobile child is highly con-cerning for child abuse. Children can
suffer ICH, such as a small subdural oran epidural hematoma underlyinga site of impact, from a short fall;however, short falls rarely result insignificant brain injury.16 Birth traumaand some medical conditions can alsoresult in ICH in infants. Consultationwith a child abuse pediatrician shouldbe considered in complex or con-cerning cases.
No studies have systematically com-pared the presentation, clinical find-ings, patterns of ICH, or presence ofretinal hemorrhages found in childrenwith bleeding disorders with thosefound in children in whom abusivehead trauma is diagnosed. However,bleeding disorders can cause ICH inany part of the cranial contents, andup to 12% of children and young adultswith bleeding disorders have hadICH at some time.22,23 Children withICH concerning for abuse require anevaluation for bleeding disorders.Exceptions to required evaluation caninclude the following:
� Independently witnessed or verifi-able trauma (abusive or nonabu-sive),
� Other findings consistent withabuse, such as fractures, burns,or internal abdominal trauma.
Other Bleeding Symptoms
Children with conditions such ashematemesis, hematochezia, or oro-nasal bleeding as presenting symp-toms should be evaluated on a case-by-case basis for possible abuse,particularly child abuse in a medicalsetting. Medical conditions and/orchild abuse can cause these findings.
BLEEDING DISORDERS ANDEXTENT OF EVALUATION
Bleeding disorders that can producepatterns of bruising or bleeding thatmimic abuse include coagulation fac-tor deficiencies/abnormalities, fibrinolytic
TABLE 1 Suspicion of Child Abuse inAmbulatory Children on the Basisof Characteristics of Bruises14,15,17
Less Suspiciousfor Child Abuse
More Suspiciousfor Child Abuse
Forehead LocationUnder chin FaceElbows EarsLower arms NeckHips Upper armsShins TrunkAnkles Hands
GenitaliaButtocksAnterior, medial thighs
PatternSlap or hand marksObject marksBite marksBruises in clustersMultiple bruises of
uniform shapeLarge cumulative size
of bruising
e1316 FROM THE AMERICAN ACADEMY OF PEDIATRICSby guest on July 7, 2016Downloaded from
defects, defects of fibrinogen, andplatelet disorders. Table 2 containsa listing of the most common bleedingdisorders in children and character-istics of potential testing strategiesfor each disorder. Most factor defi-ciencies can be detected by the pro-thrombin time (PT) and activatedpartial thromboplastin time (aPTT);however, von Willebrand disease(VWD) and factor XIII deficiency arenot reliably detected by these screen-ing tests. Additionally, mild deficienciesin factor VIII or factor IX (mild hemo-philia) might not cause abnormalitiesin the aPTT but might still result insignificant bleeding, including ICH,particularly after mild trauma. Fibri-nolytic defects can cause significantbleeding/bruising but are extremelyrare and require specific testing.Defects of fibrinogen are also rareand can be detected by the fibrinogenconcentration and thrombin time.
The prevalence of mild platelet dis-orders is unknown, and testing formild platelet disorders is challenging.The most common clinical pre-sentations include bruising and mu-cocutaneous bleeding. The prevalenceof ICH in mild platelet disorders isunknown but is likely to be low. Plateletaggregation testing, best performedby a pediatric hematologist, requiresa relatively large volume of blood, andinterpretation of the test resultrequires a specialist.25 A PFA-100 canscreen for many platelet functiondisorders, including more severetypes, such as Bernard Soulier syn-drome and Glanzmann thrombasthe-nia, as well as many types of VWD.However, the PFA-100 is not an ef-fective screen for some types of VWDand milder platelet abnormalities.Individual patient characteristics,such as hematocrit, platelet count,pregnancy, age, multisystem trauma,sepsis, and medications, can affectthe results of the PFA-100. Accurate
diagnosis often requires additionaltesting, such as specific von Wille-brand testing or platelet aggregation;therefore, many centers have de-creased or ceased use of the PFA-100.25,26 Assessment of the results ofa PFA-100 and the need for furthertesting are best accomplished inconsultation with a pediatric hema-tologist.
Vitamin K Deficiency
Vitamin K deficiency in infants canresult in bleeding in the skin or frommucosal surfaces from circumcision,generalized ecchymoses, large in-tramuscular hemorrhages, or ICH.Because of the widespread provisionof vitamin K at birth, vitamin K de-ficiency bleeding (VKDB) is rare;however, not all states require vitaminK to be administered at birth, andsome medical conditions predisposeto VKDB.24 In VKDB, there is a pro-longed PT and possibly aPTT for age. Inpatients who have already receivedvitamin K, fresh-frozen plasma, orspecific factor replacement as treat-ment, measurement of proteins in-duced by vitamin K absence canconfirm the diagnosis.27,28
Coagulation Tests in Cases ofBruising
The initial screening panel in a patientwho presents with bruising eval-uates for conditions with a knownprevalence more common than 1 per500 000 people, including idiopathicthrombocytopenic purpura, all factordeficiencies (except factor XIII de-ficiency), and VWD (Fig 1). It does notevaluate for extremely rare con-ditions, including factor XIII deficiency,defects of fibrinogen, and fibrinolyticdefects. This strategy also does notscreen for extremely rare plateletdisorders, such as Glanzmann throm-basthenia, and more common butrelatively more difficult to detect
platelet disorders, such as plateletstorage pool disorders. If test resultsare abnormal or expanded/detailedtesting is necessary or preferred,consultation with a pediatric hema-tologist is recommended.
In many circumstances, children withbruising that is suspicious for abusemay be removed from a potentiallydangerous setting where the abuselikely occurred. A thorough physi-cal examination performed in theweeks after removal that revealsminimal bruising and/or bruising onlyin locations of common accidentalbruises is supportive of abuse as thecause of the original suspiciousbruising. Each case must be evaluatedindividually, however, considering thetotality of findings, and with the un-derstanding that the need for safetymust be balanced with the emotionaltrauma of removing a child from his orher home. Bleeding disorders aregenerally permanent conditions thatdo not result in abatement aftera change in caregivers. One exceptionto this is immune thrombocytopenia(ITP), which is a transient, often self-resolving bleeding disorder. Screen-ing for ITP (platelet count) is necessaryat the time of presentation withbruises.
Determining the Need for a Test:The Medical Probability
Specific data regarding the prevalenceof bleeding disorders in the populationof children with ICH or subdural he-matoma is not available. However,there are data regarding the proba-bility of specific bleeding disorders tocause ICH. If the prevalence of a con-dition and the frequency of a particu-lar presentation of that condition areknown, a physician can construct theprobability of that specific condition(bleeding disorder) resulting in thespecific presentation (ICH). The pres-ence of “classic” bleeding symptoms,such as bleeding after circumcision,
PEDIATRICS Volume 131, Number 4, April 2013 e1317
FROM THE AMERICAN ACADEMY OF PEDIATRICS
by guest on July 7, 2016Downloaded from
TABLE2
Common
TestingStrategies
forBleeding
Disorders
Condition
Frequency
Inheritance
ScreeningTests
SnandSp,%
PPVandNPV,%
Confirm
atoryTest
Factor
abnorm
alities/deficiencies
VWDtype
11/1000
ADPFA-100
Sn=79–96
aPPV=93.3
VWAg
b
VWFactivity
Sp=88–96
aNPV=98.2
VWmultim
eranalysis
Factor
VIIIactivity
VWDtype
2AUncommon
ADor
ARPFA-100
Sn=94–100a
PPV=93.3
VWAg
b
VWFactivity
Sp=88–96
aNPV=98.2
VWmultim
eranalysis
Factor
VIIIactivity
VWDtype
2BUncommon
ADPFA-100
Sn=93–96
aPPV=93.3
VWAg
b
VWFactivity
Sp=88–96
aNPV=98.2
VWmultim
eranalysis
Factor
VIIIactivity
VWDtype
2MUncommon
ADor
ARPFA-100
Sn=94–97
aPPV=93.3
VWAg
b
VWFactivity
Sp=88–96
aNPV=98.2
VWmultim
eranalysis
Factor
VIIIactivity
VWDtype
2NUncommon
AR,orcompound
heterozygote
aPTT
NANA
VWF-Factor
VIIIbindingassay
VWDtype
31/300000–1000000
AR,orcompound
heterozygote
PFA-100
Sn=94–100a
PPV=93.3
VWAg
b
Ristocetin
cofactor
Sp=88–96
aNPV=98.2
VWFmultim
eranalysis
Factor
VIIIactivity
Factor
IIdeficiency
(prothrombin)
26reported
cases,estim
ated
1/1–2million
aPTT,PT(m
aybe
norm
al)
Sn=variable
NAFactor
IIactivity
±antigen
levels
Factor
Vdeficiency
1/1million
ARaPTT,PT
Sn=variable
NAFactor
Vactivity
CombinedFactor
V/Factor
VIIIdeficiency
1/1million
ARaPTT>PT
Sn=variable
NAFactor
Vandfactor
VIIIactivities
Factor
VIIdeficiency
1/300000–500000
ARPT
Sn=variable
NAFactor
VIIactivity
Factor
VIIIdeficiency
1/5000
malebirths
X-linked
aPTT
Sn=variable
NAFactor
VIIIactivity
Factor
IXdeficiency
1/20
000malebirths
X-linked
aPTT
Sn=variable
NAFactor
IXactivity
Factor
Xdeficiency
1/1million
ARaPTT,PT,RVV
Sn=variable
NAFactor
Xactivity
Factor
XIdeficiency
1/100000
ARaPTT
Sn=variable
NAFactor
XIactivity
Factor
XIIIdeficiency
1/2–5million
ARClot
solubility
Sn=variable
NAFactor
XIIIactivity
Fibrinolyticdefects
α-2antiplasm
indeficiency
∼40
reported
cases
AREuglobin
lysistest
Sn=variable
NAα-2antiplasm
inactivity
PAI-1
deficiency
Very
rare
ARSn
=variable
NAPAI-1antigen
andactivity
Defectsof
fibrinogen
Afibrinogenem
ia1/500000
ARPT,aPTT
Sn=high
NAFibrinogen
level
Hypofibrinogenem
iaLess
than
afibrinogenem
iaPT,aPTT
Sn=variable
NAThrombintim
e,fibrinogen
activity
Dysfibrinogenem
ia1/million
Thrombintim
e,fibrinogen
level
Sn=variable
NAThrombintim
e,fibrinogen
antigen
andactivity
levelcomparison,
reptilase
time
Platelet
disorders
ITP
Age-related
NACBC
Sn=high
NAAntiplateletAb
(rarelyneeded)
Glanzm
annthrombasthenia
Very
rare
ARPFA-100
Sn=97–100
NAPlatelet
aggregationtestingFlow
cytometry
e1318 FROM THE AMERICAN ACADEMY OF PEDIATRICSby guest on July 7, 2016Downloaded from
umbilical stump bleeding, joint hem-orrhage, and excessive soft tissuebleeding, increase the probability fora bleeding disorder; however, thesefindings are neither sensitive norspecific for bleeding disorders.
Coagulation Tests in the Setting ofICH
For bleeding disorders that cause ICH,the prevalence of the bleeding disor-der and the prevalence of ICH inpatients with each specific bleedingdisorder can be used to construct theprobability of the specific bleedingdisorder to cause ICH (Table 3). Someprobabilities are so low as to pre-clude calculation. Testing for theseconditions is likely not useful. Mildhemophilia, which might be missed ifonly an aPTT test is ordered, can bedetected by measuring specific levelsof factor VIII and factor IX. Mild he-mophilia can result in ICH, particularlyafter mild trauma, and because of therelatively high prevalence of the con-dition, the probability of mild factorVIII deficiency causing or contribut-ing to ICH is 1 in 280 000 males. Inpopulations with a high prevalenceof factor XI deficiency, such as theAshkenazi Jewish population, it might bereasonable to measure factor XI level.
Clinical and historical information canbe used to determine the need fortesting in children with isolated ICHconcerning for abuse (Fig 1). The ini-tial testing panel for ICH evaluates forconditions for which the probabilityfor the condition resulting in ICH isgreater than 1 per 5 million. The panelincludes testing for most factor defi-ciencies and afibrinogenemia. Thisscreening panel does not test forfactor XIII deficiency, VWD, fibrinolyticdefects, hypofibrinogenemia, and dys-fibrinogenemia. These conditions ei-ther have not been associated withICH or they are so rarely the cause ofICH that testing for the conditions is
not reasonable. Additionally, the initialscreening panel evaluates for dis-seminated intravascular coagulation(DIC). Because DIC can cause any typeof bruising/bleeding, including ICH,the finding of DIC in the context ofsuspected child abuse could signifi-cantly change the clinical approach toa patient. In children with DIC andbleeding symptoms as the only findingconcerning for abuse, considerationmust be given to the multitude ofprimary causes of DIC, includingtrauma, sepsis, and primary bleedingdisorders, among many others.
Many children with ICH suspicious forabuse, if they survive, are placed in safesettings after hospital discharge. Inthese cases, testing for bleeding dis-orders can be deferred to a later date,with the exception of ITP. If bloodproducts have been given to the patient,as can happen in severe ICH, the de-finitive evaluation for bleeding dis-orders should be postponed until thetransfused blood components are nolonger in the patient’s system (Table 4).Assistance from a pediatric hematolo-gist should be considered in address-ing the possibility of factor deficienciesafter a transfusion has occurred.
Many aspects of bleeding disordersare under investigation, and thus,changes in the understanding of theprevalence and severity of certainbleeding symptoms related to thesedisorders should be expected. Forexample, although hemophilia A and Bare X-linked diseases and, therefore,typically thought to affect only maleindividuals, 25% to 50% of femalecarriers of hemophilia report excessbleeding; therefore, measurement offactor VIII and IX levels in femalepatients should be considered.29 Inaddition, the population prevalenceand/or clinical effects of mild plateletfunction disorders continue to be studied.In a patient with mucocutaneous symp-toms, particularly if petechiae areTA
BLE2
Continued
Condition
Frequency
Inheritance
ScreeningTests
SnandSp,%
PPVandNPV,%
Confirm
atoryTest
BernardSouliersyndrome
Rare
ARPFA-100
Sn=100
NAPlatelet
aggregationtestingFlow
cytometry
Platelet
release/storagedisorders
Unknow
n,morecommon
than
otherplatelet
functiondisorders
variable
PFA-100
Sn=27–50
NAPlatelet
aggregationandsecretion
Electron
microscopy
Molecular
andcytogenetic
testing
AD,autosom
aldominant;AR,autosom
alrecessive;CBC,completebloodcell(count);NA,not
availableor
notapplicable;NPV,negativepredictivevalue;PAI-1,plasm
inogen
activator
inhibitor-1;PPV,positivepredictivevalue;RVV,Russellviper
venom
(test);S
n,sensitivity;S
p,specificity;VW,von
Willebrand;VWAg,von
Willebrand
antigen;VWF,vonWillebrand
factor
Ab,antibody.
aValues
derivedfrom
data
before
2008
NationalInstitutesof
Health
Consensusguidelines.S
nandSp
usingcurrentdiagnosticcutoffs
unknow
nbutwould
beexpected
tohave
higher
Spwith
lower
Sn.
bMay
bereasonable
toproceeddirectlyto
diagnostictestingdependingon
availability.Seeaccompanyingtechnicalreport
fordetaileddiscussion.24
PEDIATRICS Volume 131, Number 4, April 2013 e1319
FROM THE AMERICAN ACADEMY OF PEDIATRICS
by guest on July 7, 2016Downloaded from
present, platelet aggregation testingshould be considered.25 Finally, be-cause von Willebrand factor is anacute phase reactant, its levels canvary in response to clinical status,resulting in falsely elevated results.Many times, testing must be repeatedup to 3 times to ensure reliableresults.30 If significant concern forVWD exists, consultation with a pedi-atric hematologist is suggested.
When Testing Indicates a PossibleBleeding Disorder in the Context ofan Abuse Evaluation
Positive laboratory test results requirefurther evaluation for the possibility offalse-positive results and/or the ne-
cessity for further testing. Pro-longation of the PTand aPTT because ofparenchymal damage has been notedin abusive head trauma and should notautomatically be interpreted as evi-dence of a primary bleeding disor-der.31 Additionally, consideration mustbe given to the likelihood of a preex-isting bleeding disorder as the pri-mary cause of a child’s bleeding/bruising. For example, given the rela-tively high prevalence of VWD, it isinevitable that some children withVWD will be abused and present withbleeding/bruising symptoms. Deter-mining the causative factor in thesesituations is challenging. Bruising isa common finding in VWD. If a childhas test results consistent with VWDand bruising concerning for abuse,a short-term change in home settingmay be considered, understandingthe cautions needed when using thisapproach. Only a few case reportshave attributed ICH to VWD. Mostreported ICH in children with VWDwould not be confused with typicalabusive ICH.32–34 Given the rarity ofICH in VWD, particularly spontaneousICH, testing consistent with VWD doesnot mean that ICH is definitively at-tributable to VWD, and abuse muststill be considered.
Interpretation of Tests
It should be noted that the aPTT can befalsely prolonged in certain circum-stances, such as in the presence ofa lupus anticoagulant, or can be pro-longed and might not indicate a truebleeding disorder, such as in factor XIIdeficiency or other contact factordeficiencies. In addition, patients whoexperience a traumatic brain injuryoften have a transient coagulopathythat does not reflect an underlyingcongenital disorder.31,35 Coagulationtests are very sensitive to specimenhandling and should be performed inlaboratories experienced with theseassays. Inappropriate handling com-monly leads to false-positive results.
CONCLUSIONS
Children who present with bleedingand bruising symptoms that are con-cerning for abuse require carefulevaluation for the potential of bleedingdisorders as a cause. No single panelof tests rules out every possiblebleeding disorder. Given the rarity ofmost bleeding disorders and thepossible presence of specific clinicalfactors that decrease the likelihood ofa bleeding disorder causing a child’sfindings, in many situations, exten-sive laboratory evaluation is not
TABLE 3 Probabilities for Congenital Coagulopathies Causing ICHa
Condition Prevalence of Condition,Upper Limits
Prevalence of ICH, Upper Limits Probabilityb
VWD 1/1000 Extremely rare LowFactor II deficiency 1/1 million 11% 1/10 millionFactor V deficiency 1/1 million 8% of homozygotes 1/10 million homozygotesCombined factors V and VIII deficiencies 1/1 million 2% 1/50 millionFactor VII deficiency 1/300 000 4%–6.5% 1/5 millionFactor VIII deficiency 1/5000 males 5%–12% 1/50 000 malesFactor IX deficiency 1/20 000 males 5%–12% 1/200 000 malesFactor X deficiency 1/1 million 21% 1/5 millionFactor XI deficiency 1/100 000 Extremely rare LowFactor XIII deficiency 1/2 million 33% 1/6 millionα-2 antiplasmin deficiency 40 cases reported Not reported LowPlasminogen activator inhibitor-1 deficiency Extremely rare Common LowAfibrinogenemia 1/500 000 10% 1/5 millionDysfibrinogenemia 1/1 million Single case report Lowa The probability of having a specific bleeding disorder increases in the setting of a family history of that specific named bleeding disorder or if the patient is from an ethnicity in whicha specific bleeding disorder is more common (eg, Ashkenazi Jewish people and factor XI deficiency).b“Probability” indicates the probability that an individual in the general population would have the following specific coagulopathy causing an ICH.
TABLE 4 Half-Lives of Coagulation Factors
Factor Half-Life Postinfusion, h
Fibrinogen 96–150II 60V 24VII 4–6VIII 11–12IX 22X 35XI 60XIII 144–300VWF 8–12
VWF, von Willebrand factor.Reprinted with permission from Goodnight S, HathawayW. Disorders of Hemostasis and Thrombosis: A ClinicalGuide. 2nd ed. New York, NY: McGraw-Hill Professional;2001:497.
e1320 FROM THE AMERICAN ACADEMY OF PEDIATRICSby guest on July 7, 2016Downloaded from
necessary. If a laboratory evaluation isconducted, tests should be chosen onthe basis of the prevalence of thecondition, patient and family history,ease of testing, blood volume requiredfor testing, and, in the case of ICH,probability of a bleeding disordercausing ICH. Further consultation witha pediatric hematologist is recom-mended if specific, expanded testingis necessary, if preliminary testingsuggests the presence of a bleedingdisorder, if testing to rule out a spe-cific bleeding disorder is needed, or iftesting for very rare conditions ispreferred.
GUIDANCE FOR PEDIATRICIANS
In children who have bruising orbleeding that is suspicious for abuse,
1. Complete medical, trauma, andfamily histories and a thoroughphysical examination are criticaltools in evaluating for the possibil-ity of abuse or medical conditionsthat predispose to bleeding/bruis-ing.
2. In each case, careful considera-tion of the possibility of a medicalcondition causing the bleeding/bruising is essential. Specific ele-ments of the history and character-istics of the bleeding/bruising canbe used to determine the need fora laboratory evaluation for bleed-ing disorders.
3. If the evaluation indicates a needfor laboratory testing for bleedingdisorders, initial testing is focused
on the prevalence of the conditionand potential of each specific con-dition to cause the specific findingsin a given child (Fig 1).
4. Laboratory testing suggestive or in-dicating the presence of a bleed-ing disorder does not eliminateabuse from consideration. In chil-dren with bruising and laboratorytesting suggestive of a bleedingdisorder, a follow-up evaluation af-ter a change in home setting canprovide valuable information re-garding the likelihood of a bleedingdisorder causing the concerningfindings.
5. Children with ICH often receiveblood product transfusions. It issuggested that screening for bleed-ing disorders in these patients bedelayed until elimination of thetransfused blood clotting elements.
6. The discovery of new informationregarding condition prevalence,laboratory testing, and clinical pre-sentations of bleeding disordersis to be expected. Close collabora-tion with a pediatric hematologistis necessary to ensure the mostcurrent evaluation and testingmethods.
LEAD AUTHORSJames D. Anderst, MD, MSShannon L. Carpenter, MD, MSThomas C. Abshire, MD
SECTION ON HEMATOLOGY/ONCOLOGYEXECUTIVE COMMITTEE, 2012–2013Jeffrey Hord, MD, ChairpersonGary Crouch, MD
Gregory Hale, MDBrigitta Mueller, MDZora Rogers, MDPatricia Shearer, MDEric Werner, MD, Immediate Past Chairperson
FORMER EXECUTIVE COMMITTEEMEMBERSStephen Feig, MDEric Kodish, MDAlan Gamis, MD
LIAISONSEdwin Forman, MD — Alliance for ChildhoodCancer
CONSULTANTShannon Carpenter, MD, MSThomas Abshire, MD
STAFFSuzanne Kirkwood, MS
COMMITTEE ON CHILD ABUSE ANDNEGLECT, 2012–2013Cindy W. Christian, MD, ChairpersonJames Crawford-Jakubiak, MDEmalee Flaherty, MDJohn M. Leventhal, MDJames Lukefahr, MDRobert Sege, MD PhD
LIAISONSHarriet MacMillan, MD— American Academy ofChild and Adolescent PsychiatryCatherine Nolan, MSW — ACSW, Administrationfor Children, Youth, and Families, Office onChild Abuse and NeglectJanet Saul, PhD — Centers for Disease Controland Prevention
CONSULTANTJames Anderst, MD, MS
STAFFTammy Piazza HurleySonya Clay
REFERENCES
1. Lieder HS, Irving SY, Mauricio R, Graf JM.Munchausen syndrome by proxy: a case re-port. AACN Clin Issues. 2005;16(2):178–184
2. Ulinski T, Lhopital C, Cloppet H, et al.Munchausen syndrome by proxy with mas-sive proteinuria and gastrointestinal hem-orrhage. Pediatr Nephrol. 2004;19(7):798–800
3. Stricker T, Lips U, Sennhauser FH.Oral bleeding: Child abuse alert. JPaediatr Child Health. 2002;38(5):528–529
4. Walton LJ, Davies FC. Nasal bleeding andnon-accidental injury in an infant. Arch DisChild. 2010;95(1):53–54
5. Paranjothy S, Fone D, Mann M, et al. Theincidence and aetiology of epistaxis ininfants: a population-based study. Arch DisChild. 2009;94(6):421–424
6. McIntosh N, Mok JY, Margerison A. Epide-miology of oronasal hemorrhage in thefirst 2 years of life: implications for child
PEDIATRICS Volume 131, Number 4, April 2013 e1321
FROM THE AMERICAN ACADEMY OF PEDIATRICS
by guest on July 7, 2016Downloaded from
protection. Pediatrics. 2007;120(5):1074–1078
7. Goodnight S, Hathaway W. Disorders ofHemostasis and Thrombosis: A ClinicalGuide. 2nd ed. New York, NY: McGraw-Hill;2001
8. Anderst JD, Kellogg N, Jung I. Is the di-agnosis of physical abuse changed whenChild Protective Services consults a ChildAbuse Pediatrics subspecialty group asa second opinion? Child Abuse Negl. 2009;33(8):481–489
9. O’Hare AE, Eden OB. Bleeding disorders andnon-accidental injury. Arch Dis Child. 1984;59(9):860–864
10. Scimeca PG, Cooper LB, Sahdev I. Suspicionof child abuse complicating the diagnosisof bleeding disorders. Pediatr HematolOncol. 1996;13(2):179–182
11. Jenny C, Hymel KP, Ritzen A, Reinert SE, HayTC. Analysis of missed cases of abusivehead trauma. JAMA. 1999;281(7):621–626
12. Sugar NF, Taylor JA, Feldman KW; PugetSound Pediatric Research Network. Bruisesin infants and toddlers: those who don’tcruise rarely bruise. Arch Pediatr AdolescMed. 1999;153(4):399–403
13. Carpenter RF. The prevalence and distri-bution of bruising in babies. Arch Dis Child.1999;80(4):363–366
14. Maguire S, Mann MK, Sibert J, Kemp A. Arethere patterns of bruising in childhoodwhich are diagnostic or suggestive ofabuse? A systematic review. Arch Dis Child.2005;90(2):182–186
15. Jenny C, Reese R. Cutaneous manifes-tations of child abuse. In: Reese RM,Christian CW, eds. Child Abuse Medical Di-agnosis and Management. 3rd ed. Chi-cago, IL: American Academy of Pediatrics;2009:19–51
16. Chadwick DL, Bertocci G, Castillo E, et al.Annual risk of death resulting from short
falls among young children: less than 1 in 1million. Pediatrics. 2008;121(6):1213–1224
17. Dunstan FD, Guildea ZE, Kontos K, Kemp AM,Sibert JR. A scoring system for bruisepatterns: a tool for identifying abuse. ArchDis Child. 2002;86(5):330–333
18. Feldman KW. Patterned abusive bruises ofthe buttocks and the pinnae. Pediatrics.1992;90(4):633–636
19. Jackson J, Carpenter SL, Anderst JD. Chal-lenges in the evaluation for possible abuse:presentations of congenital bleeding dis-orders in childhood. Child Abuse Negl.2012;36(2):127–134
20. Sirotnak AP. Medical disorders that mimicabusive head trauma. In: Frasier L, Rauth-Farley K, Alexander R, Parrish R, eds. Abu-sive Head Trauma in Infants and Children.St Louis, MO: G W Medical Publishing; 2006:191–214
21. Dinehart SM, Henry L. Dietary supplements:altered coagulation and effects on bruis-ing. Dermatol Surg. 2005;31(7 pt 2):819–826, discussion 826
22. Mishra P, Naithani R, Dolai T, et al. In-tracranial haemorrhage in patients withcongenital haemostatic defects. Haemo-philia. 2008;14(5):952–955
23. Nelson MD, Jr, Maeder MA, Usner D, et al.Prevalence and incidence of intracranialhaemorrhage in a population of childrenwith haemophilia. The Hemophilia Growthand Development Study. Haemophilia. 1999;5(5):306–312
24. Carpenter SL, Abshire T, Anderst JD;American Academy of Pediatrics, Sectionon Hematology/Oncology and Committee onChild Abuse and Neglect. Technical report:evaluation for conditions that predisposeto bleeding when child abuse is suspected.Pediatrics. 2012; (in press)
25. Hayward CPM, Rao AK, Cattaneo M. Congen-ital platelet disorders: overview of their
mechanisms, diagnostic evaluation andtreatment. Haemophilia. 2006;12(suppl 3):128–136
26. Nichols WL, Hultin MB, James AH, et al. vonWillebrand disease (VWD): evidence-baseddiagnosis and management guidelines, theNational Heart, Lung, and Blood Institute(NHLBI) Expert Panel report (USA). Hae-mophilia. 2008;14(2):171–232
27. Shearer MJ. Vitamin K deficiency bleeding(VKDB) in early infancy. Blood Rev. 2009;23(2):49–59
28. Miyasaka M, Nosaka S, Sakai H, et al. Vi-tamin K deficiency bleeding with in-tracranial hemorrhage: focus on secondaryform. Emerg Radiol. 2007;14(5):323–329
29. Plug I, Mauser-Bunschoten EP, Bröcker-Vriends AH, et al. Bleeding in carriers ofhemophilia. Blood. 2006;108(1):52–56
30. National Heart, Lung, and Blood Institute.The Diagnosis, Evaluation and Managementof von Willebrand Disease. Bethesda, MD:National Heart, Lung, and Blood Institute,National Institutes of Health, US De-partment of Health and Human Services;December 2007. NIH Publication No. 08-5832
31. Hymel KP, Abshire TC, Luckey DW, Jenny C.Coagulopathy in pediatric abusive headtrauma. Pediatrics. 1997;99(3):371–375
32. Ragni MV, Bontempo FA, Hassett AC. vonWillebrand disease and bleeding in women.Haemophilia. 1999;5(5):313–317
33. Ziv O, Ragni MV. Bleeding manifestations inmales with von Willebrand disease. Hae-mophilia. 2004;10(2):162–168
34. Mizoi K, Onuma T, Mori K. Intracranialhemorrhage secondary to von Willebrand’sdisease and trauma. Surg Neurol. 1984;22(5):495–498
35. Talving P, Lustenberger T, Lam L, et al.Coagulopathy after isolated severe trau-matic brain injury in children. J Trauma.2011;71(5):1205–1210
e1322 FROM THE AMERICAN ACADEMY OF PEDIATRICSby guest on July 7, 2016Downloaded from
DOI: 10.1542/peds.2013-0195; originally published online March 25, 2013; 2013;131;e1314Pediatrics
NEGLECTHEMATOLOGY/ONCOLOGY and COMMITTEE ON CHILD ABUSE AND
James D. Anderst, Shannon L. Carpenter, Thomas C. Abshire and the SECTION ONEvaluation for Bleeding Disorders in Suspected Child Abuse
ServicesUpdated Information &
/content/131/4/e1314.full.htmlincluding high resolution figures, can be found at:
References
/content/131/4/e1314.full.html#ref-list-1at:This article cites 30 articles, 11 of which can be accessed free
Citations /content/131/4/e1314.full.html#related-urls
This article has been cited by 8 HighWire-hosted articles:
Subspecialty Collections
/cgi/collection/child_abuse_neglect_subChild Abuse and Neglect
/cgi/collection/section_on_hematology_oncologySection on Hematology/Oncology
/cgi/collection/committee_on_child_abuse_and_neglectCommittee on Child Abuse and Neglectthe following collection(s):This article, along with others on similar topics, appears in
Permissions & Licensing
/site/misc/Permissions.xhtmltables) or in its entirety can be found online at: Information about reproducing this article in parts (figures,
Reprints /site/misc/reprints.xhtml
Information about ordering reprints can be found online:
rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Grove Village, Illinois, 60007. Copyright © 2013 by the American Academy of Pediatrics. All and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elkpublication, it has been published continuously since 1948. PEDIATRICS is owned, published, PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on July 7, 2016Downloaded from
DOI: 10.1542/peds.2013-0195; originally published online March 25, 2013; 2013;131;e1314Pediatrics
NEGLECTHEMATOLOGY/ONCOLOGY and COMMITTEE ON CHILD ABUSE AND
James D. Anderst, Shannon L. Carpenter, Thomas C. Abshire and the SECTION ONEvaluation for Bleeding Disorders in Suspected Child Abuse
/content/131/4/e1314.full.html
located on the World Wide Web at: The online version of this article, along with updated information and services, is
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2013 by the American Academy published, and trademarked by the American Academy of Pediatrics, 141 Northwest Pointpublication, it has been published continuously since 1948. PEDIATRICS is owned, PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
by guest on July 7, 2016Downloaded from